Genmab — Maj 2024

[E_L]

I doubt that, we will get cervical & head and neck cancer at ASCO though. head and neck should be the next area to go into; they said they will speak with regulators about the next steps for that

[E_L]

i would be surprised to see them go further with NSCLC, there is so much competition there... but i don't mind being surprised I would have expected ovarian cancer to be more logical

[Solsen]

If they se a chance they will persue it. Huge market.

[ProinvestorNEWS]

Transactions in Connection with Share Buy-back Program https://www.proinvestor.com/investornyt/1155522/transactions-in-connection-with-share-buy-back-program

[E_L]

BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/05/06/biontech-se-bntx-q1-2024-earnings-call-transcript/

[E_L]

morningstar - Genmab’s results are tracking our expectations, and we maintain our fair value estimate of DKK 2,650 per share. https://www.morningstar.com/stocks/xcse/gmab/quote

[Vitus]

Genmab aktien har ikke specielt svært ved at droppe under kurs 2000

[Pensionisten]

Ja, det er p.t. lidt svært at se lyspunkterne i Genmab aktien. Lide

[Pensionisten]

Lidt : Dead man walking...

[ProinvestorNEWS]

Kort ugevideo: Speedsnak om Genmab, Gubra, Zealand Pharma, Bakkafrost, Avance Gas, BW-LPG m.fl https://www.proinvestor.com/boards/120315

[Bulder]

Mim8 https://borsen.dk/nyheder/virksomheder/novo-chef-om-stillestaaende-division-nyt-om-faa-uger?b_source=seneste-nyt\&b_medium=row_1\&b_campaign=list_21

[w]

Mim8 medwatch https://medwatch.dk/article17087988.ece

[Bulder]

milestones of up to approximately $ 250 million as well as mid-single digit royalties on successful products

[JKY_VH]

Det lyder godt

[Raun]

Spændende

[Pensionisten]

Lyder mere end godt - håber, at den kommer i land. Det vil være pragtfuldt

[Vougeot]

Øv, så skal vi ned imorgen

[JKY_VH]

Mon ikke Novo ved, hvilken vej hønsene skraber siden man klemmer den ud på et investormøde ?

[bikube]

Warrants er ikke mange denne gang og til over 1000 kr./stk.

[Helge_LarsenPI-redaktør]

Capital Increase in Genmab as a Result of Employee Warrant Exercise https://www.proinvestor.com/investornyt/1156329/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise